Luliconazole

Luliconazole
Clinical data
Trade names	Luzu, Luzarn, Lulicon, LULY, Zyluli
Routes of; administration	Topical
ATC code	D01AC18 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Pharmacokinetic data
Protein binding	>99%
Identifiers
	IUPAC name (2E)-[(4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene](1H-imidazol-1-yl)acetonitrile;
CAS Number	187164-19-8;
PubChem CID	3003141;
ChemSpider	2273807;
UNII	RE91AN4S8G;
CompTox Dashboard (EPA)	DTXSID3048607 ;
Chemical and physical data
Formula	C14H9Cl2N3S2
Molar mass	354.27 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl;
	InChI InChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1; Key:YTAOBBFIOAEMLL-REQDGWNSSA-N;

Luliconazole, trade names Luzu among others, is an imidazole antifungal medication. As a 1% topical cream, It is indicated for the treatment of athlete's foot, jock itch, and ringworm caused by dermatophytes such as Trichophyton rubrum, Microsporum gypseum^[2] and Epidermophyton floccosum.^[1]

References

^ ^a ^b "LUZU (luliconazole) Cream, 1%. Full Prescribing Information" (PDF). Valeant Pharmaceuticals North America LLC. Retrieved 1 October 2015.
^ "FDA approves luliconazole for tinea pedis". November 19, 2013. Archived from the original on 16 January 2014. Retrieved 14 January 2014.

This dermatologic drug article is a stub. You can help Wikipedia by expanding it.